Regional variation in prevalence and healthcare utilization due to epilepsy in Sweden-Reference-Cited by-同舟云学术

Regional variation in prevalence and healthcare utilization due to epilepsy in Sweden

Published:2014-07-18 Issue:6 Volume:130 Page:354-359
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

Bolin K.¹²,Berggren F.³,Landtblom A.-M.⁴

Affiliation:

1. Department of Economics; University of Gothenburg; Gothenburg Sweden

2. Centre for Health Economics at University of Gothenburg; Gothenburg Sweden

3. UCB Pharma; Copenhagen Denmark

4. Department of Clinical and Experimental Medicine/Neurology; University of Linköping; UHL County Council; Linköping Sweden

Funder

UCB Pharma

Publisher

Wiley

Subject

Clinical Neurology,Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ane.12274/fullpdf

Reference14 articles.

1. National Board of Health and Welfare Kvalitet och effektivitet - Jämförelser mellan landsting 2012

2. Ringbäck Weitoft G. Sociodemographic differences in antiepileptic drug prescriptions to adult epilepsy patients;Mattsson;Neurology,2010

3. Cost of disorders of the brain in Europe 2010;Gustavsson;Eur Neuropsychopharmacol,2011

4. Medical Products Agency (Läkemedelsverket) Läkemedelsbehandling av epilepsi - Bakgrundsdokumentation (Pharmaceutical treatment of epilepsy - a documentation) 2011

5. Epilepsy in Sweden: healthcare costs and loss of productivity - a register-based approach;Bolin;Eur J Health Econ,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic and social cost of epilepsy in Poland: 5-year analysis;The European Journal of Health Economics;2021-02-13

2. High‐resolution mapping of epilepsy prevalence, ambulance use, and socioeconomic deprivation in an urban area of Sweden;Epilepsia;2019-09-16

3. Geographical variations in patient-reported outcomes after total hip arthroplasty between 2008 - 2012;BMC Health Services Research;2019-05-30

4. Prevalence of non-febrile seizures in children with idiopathic autism spectrum disorder and their unaffected siblings: a retrospective cohort study;BMC Neurology;2016-11-28

5. Regional disparities in botulinum toxin A (BoNT-A) therapy for spasticity in Sweden: budgetary consequences of closing the estimated treatment gap;Acta Neurologica Scandinavica;2016-05-24